Clonogenic capacity and ex vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation

C. Almici, C. Carlo-Stella, J. E. Wagner, L. Mangoni, D. Garau, A. Re, R. Giachetti, C. Cesana, V. Rizzoli

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Umbilical cord blood (UCB) progenitor cells have been demonstrated to possess significant advantages over bone marrow (BM), in terms of proliferative capacity and immunologic reactivity. Therefore UCB has been recently been considered an attractive potential alternative to BM as a source of hematopoietic progenitor cells for clinical applications. Since several programs throughout the world are currently evaluating the feasibility of large-scale UCB banking for unrelated transplants, it was the aim of this study to evaluate whether cypropreservation procedures might heavily impair the clonogenic capacity, the feasibility of CD34+ selection and the ex vivo expansion potential of UCB progenitor cells. UCB samples were collected and cypropreserved as unseparated (n = 21) or mononuclear (MNC) cells (n = 15) within 12 h from delivery, and evaluated for viability, immunophenotype, cell and progenitor numbers after a minimum stay in liquid nitrogen of 6 months (range 6-14 months). Viability was always > 97% and no statistically significant difference was detected by flow cytometric analysis. Clonogenic recovery from unseparated cells was 80-87% for HPP-CFC, CFU-GEMM, BFU-E and CFU-GM, and from MNC cells ranged from 82 to 91% for LTC-IC, CFU-GEMM, BFU-E and CFU-GM. CD34+ selection (n = 8) was performed on fresh and cypropreserved MNC cells using the MiniMACS immunomagnetic separation device, showing no difference in yield (68 ± 7%, vs 57 ± 4%, P ≤ 0.4) or in purity (89 ± 2% vs 81 ± 6%, ≤ 0.4), for fresh in comparison to cypropreserved MNC cells, After 14 days of liquid culture in the presence of different combinations of SCF, IL-3, IL-6 and G-CSF no statistically significant difference was detected in CFC fold-expansion for fresh or cypropreserved MNC cells and for CD34+ cells, either selected and cultured from fresh or cypropreserved MNC cells. In conclusion we can state that UCB is a potential source of primitive progenitor cells that can be cypropreserved unmanipulated or after physical separation without major losses in clonogenic capacity and immunophenotypic composition. More-over, CD34+ selection from cypropreserved MNC cells is feasible and ex vivo expansion is not impaired. These results have important implications in the large scale UCB banking, in view of the potential applications of ex vivo expanded hematopoietic progenitor cells for the engraftment of adult patients.

Original languageEnglish
Pages (from-to)1079-1084
Number of pages6
JournalBone Marrow Transplantation
Volume19
Issue number11
Publication statusPublished - Jun 1 1997

Fingerprint

Cryopreservation
Fetal Blood
Blood Cells
Stem Cells
Myeloid Progenitor Cells
Blood Banks
Granulocyte-Macrophage Progenitor Cells
Erythroid Precursor Cells
Hematopoietic Stem Cells
Bone Marrow
Immunomagnetic Separation
Interleukin-3
Granulocyte Colony-Stimulating Factor
Interleukin-6
Nitrogen
Cell Count
Transplants
Equipment and Supplies

Keywords

  • CD34 selection
  • Cryopreservation
  • Ex vivo expansion
  • Progenitor cells
  • Umbilical cord blood

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Clonogenic capacity and ex vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation. / Almici, C.; Carlo-Stella, C.; Wagner, J. E.; Mangoni, L.; Garau, D.; Re, A.; Giachetti, R.; Cesana, C.; Rizzoli, V.

In: Bone Marrow Transplantation, Vol. 19, No. 11, 01.06.1997, p. 1079-1084.

Research output: Contribution to journalArticle

Almici, C, Carlo-Stella, C, Wagner, JE, Mangoni, L, Garau, D, Re, A, Giachetti, R, Cesana, C & Rizzoli, V 1997, 'Clonogenic capacity and ex vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation', Bone Marrow Transplantation, vol. 19, no. 11, pp. 1079-1084.
Almici, C. ; Carlo-Stella, C. ; Wagner, J. E. ; Mangoni, L. ; Garau, D. ; Re, A. ; Giachetti, R. ; Cesana, C. ; Rizzoli, V. / Clonogenic capacity and ex vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation. In: Bone Marrow Transplantation. 1997 ; Vol. 19, No. 11. pp. 1079-1084.
@article{7fe94df42f6545f8889db5cb52abd4f0,
title = "Clonogenic capacity and ex vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation",
abstract = "Umbilical cord blood (UCB) progenitor cells have been demonstrated to possess significant advantages over bone marrow (BM), in terms of proliferative capacity and immunologic reactivity. Therefore UCB has been recently been considered an attractive potential alternative to BM as a source of hematopoietic progenitor cells for clinical applications. Since several programs throughout the world are currently evaluating the feasibility of large-scale UCB banking for unrelated transplants, it was the aim of this study to evaluate whether cypropreservation procedures might heavily impair the clonogenic capacity, the feasibility of CD34+ selection and the ex vivo expansion potential of UCB progenitor cells. UCB samples were collected and cypropreserved as unseparated (n = 21) or mononuclear (MNC) cells (n = 15) within 12 h from delivery, and evaluated for viability, immunophenotype, cell and progenitor numbers after a minimum stay in liquid nitrogen of 6 months (range 6-14 months). Viability was always > 97{\%} and no statistically significant difference was detected by flow cytometric analysis. Clonogenic recovery from unseparated cells was 80-87{\%} for HPP-CFC, CFU-GEMM, BFU-E and CFU-GM, and from MNC cells ranged from 82 to 91{\%} for LTC-IC, CFU-GEMM, BFU-E and CFU-GM. CD34+ selection (n = 8) was performed on fresh and cypropreserved MNC cells using the MiniMACS immunomagnetic separation device, showing no difference in yield (68 ± 7{\%}, vs 57 ± 4{\%}, P ≤ 0.4) or in purity (89 ± 2{\%} vs 81 ± 6{\%}, ≤ 0.4), for fresh in comparison to cypropreserved MNC cells, After 14 days of liquid culture in the presence of different combinations of SCF, IL-3, IL-6 and G-CSF no statistically significant difference was detected in CFC fold-expansion for fresh or cypropreserved MNC cells and for CD34+ cells, either selected and cultured from fresh or cypropreserved MNC cells. In conclusion we can state that UCB is a potential source of primitive progenitor cells that can be cypropreserved unmanipulated or after physical separation without major losses in clonogenic capacity and immunophenotypic composition. More-over, CD34+ selection from cypropreserved MNC cells is feasible and ex vivo expansion is not impaired. These results have important implications in the large scale UCB banking, in view of the potential applications of ex vivo expanded hematopoietic progenitor cells for the engraftment of adult patients.",
keywords = "CD34 selection, Cryopreservation, Ex vivo expansion, Progenitor cells, Umbilical cord blood",
author = "C. Almici and C. Carlo-Stella and Wagner, {J. E.} and L. Mangoni and D. Garau and A. Re and R. Giachetti and C. Cesana and V. Rizzoli",
year = "1997",
month = "6",
day = "1",
language = "English",
volume = "19",
pages = "1079--1084",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Clonogenic capacity and ex vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation

AU - Almici, C.

AU - Carlo-Stella, C.

AU - Wagner, J. E.

AU - Mangoni, L.

AU - Garau, D.

AU - Re, A.

AU - Giachetti, R.

AU - Cesana, C.

AU - Rizzoli, V.

PY - 1997/6/1

Y1 - 1997/6/1

N2 - Umbilical cord blood (UCB) progenitor cells have been demonstrated to possess significant advantages over bone marrow (BM), in terms of proliferative capacity and immunologic reactivity. Therefore UCB has been recently been considered an attractive potential alternative to BM as a source of hematopoietic progenitor cells for clinical applications. Since several programs throughout the world are currently evaluating the feasibility of large-scale UCB banking for unrelated transplants, it was the aim of this study to evaluate whether cypropreservation procedures might heavily impair the clonogenic capacity, the feasibility of CD34+ selection and the ex vivo expansion potential of UCB progenitor cells. UCB samples were collected and cypropreserved as unseparated (n = 21) or mononuclear (MNC) cells (n = 15) within 12 h from delivery, and evaluated for viability, immunophenotype, cell and progenitor numbers after a minimum stay in liquid nitrogen of 6 months (range 6-14 months). Viability was always > 97% and no statistically significant difference was detected by flow cytometric analysis. Clonogenic recovery from unseparated cells was 80-87% for HPP-CFC, CFU-GEMM, BFU-E and CFU-GM, and from MNC cells ranged from 82 to 91% for LTC-IC, CFU-GEMM, BFU-E and CFU-GM. CD34+ selection (n = 8) was performed on fresh and cypropreserved MNC cells using the MiniMACS immunomagnetic separation device, showing no difference in yield (68 ± 7%, vs 57 ± 4%, P ≤ 0.4) or in purity (89 ± 2% vs 81 ± 6%, ≤ 0.4), for fresh in comparison to cypropreserved MNC cells, After 14 days of liquid culture in the presence of different combinations of SCF, IL-3, IL-6 and G-CSF no statistically significant difference was detected in CFC fold-expansion for fresh or cypropreserved MNC cells and for CD34+ cells, either selected and cultured from fresh or cypropreserved MNC cells. In conclusion we can state that UCB is a potential source of primitive progenitor cells that can be cypropreserved unmanipulated or after physical separation without major losses in clonogenic capacity and immunophenotypic composition. More-over, CD34+ selection from cypropreserved MNC cells is feasible and ex vivo expansion is not impaired. These results have important implications in the large scale UCB banking, in view of the potential applications of ex vivo expanded hematopoietic progenitor cells for the engraftment of adult patients.

AB - Umbilical cord blood (UCB) progenitor cells have been demonstrated to possess significant advantages over bone marrow (BM), in terms of proliferative capacity and immunologic reactivity. Therefore UCB has been recently been considered an attractive potential alternative to BM as a source of hematopoietic progenitor cells for clinical applications. Since several programs throughout the world are currently evaluating the feasibility of large-scale UCB banking for unrelated transplants, it was the aim of this study to evaluate whether cypropreservation procedures might heavily impair the clonogenic capacity, the feasibility of CD34+ selection and the ex vivo expansion potential of UCB progenitor cells. UCB samples were collected and cypropreserved as unseparated (n = 21) or mononuclear (MNC) cells (n = 15) within 12 h from delivery, and evaluated for viability, immunophenotype, cell and progenitor numbers after a minimum stay in liquid nitrogen of 6 months (range 6-14 months). Viability was always > 97% and no statistically significant difference was detected by flow cytometric analysis. Clonogenic recovery from unseparated cells was 80-87% for HPP-CFC, CFU-GEMM, BFU-E and CFU-GM, and from MNC cells ranged from 82 to 91% for LTC-IC, CFU-GEMM, BFU-E and CFU-GM. CD34+ selection (n = 8) was performed on fresh and cypropreserved MNC cells using the MiniMACS immunomagnetic separation device, showing no difference in yield (68 ± 7%, vs 57 ± 4%, P ≤ 0.4) or in purity (89 ± 2% vs 81 ± 6%, ≤ 0.4), for fresh in comparison to cypropreserved MNC cells, After 14 days of liquid culture in the presence of different combinations of SCF, IL-3, IL-6 and G-CSF no statistically significant difference was detected in CFC fold-expansion for fresh or cypropreserved MNC cells and for CD34+ cells, either selected and cultured from fresh or cypropreserved MNC cells. In conclusion we can state that UCB is a potential source of primitive progenitor cells that can be cypropreserved unmanipulated or after physical separation without major losses in clonogenic capacity and immunophenotypic composition. More-over, CD34+ selection from cypropreserved MNC cells is feasible and ex vivo expansion is not impaired. These results have important implications in the large scale UCB banking, in view of the potential applications of ex vivo expanded hematopoietic progenitor cells for the engraftment of adult patients.

KW - CD34 selection

KW - Cryopreservation

KW - Ex vivo expansion

KW - Progenitor cells

KW - Umbilical cord blood

UR - http://www.scopus.com/inward/record.url?scp=0030983279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030983279&partnerID=8YFLogxK

M3 - Article

C2 - 9193749

AN - SCOPUS:0030983279

VL - 19

SP - 1079

EP - 1084

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 11

ER -